RARRES2参与骨髓瘤干细胞和瘤相关的巨细胞之间的"锁钥匙"相互作用
Jingjin Ma1, Zhiyu Chen1, Qiaochu Li1
1Department of Orthopedics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Scientific reports
|January 27, 2024
概括
骨髓瘤干细胞 (OSCs) 驱动药物耐药性和复发. 这项研究揭示了OSC的异质性,并确定了IGF-RARRES2轴,涉及瘤相关的巨细胞,对于维持OSC干性至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 骨髓瘤 (OS) 是一种主要的骨恶性瘤.
- 骨髓瘤干细胞 (OSC) 有助于治疗耐药性,疾病复发和免疫抑制.
- 了解OSC异质性及其与瘤微环境的相互作用,对于开发有效的治疗方法至关重要.
研究的目的:
- 在OS瘤微环境中研究OSC的异质性.
- 阐明由OSCs与瘤相关巨细胞 (TAMs) 之间的相互作用驱动的免疫抑制机制.
- 为了确定关键的分子参与者和通信途径,涉及到OSC树干性维护.
主要方法:
- 单细胞转录组学被用来分析OS细胞组件,轨迹和细胞间通信.
- 计算分析确定了细胞通信模式,枢纽基因和恶性细胞子组,包括OSC.
- 实验室和患者研究验证了关键发现,包括特定基因和细胞因子的作用.
主要成果:
- OSCs表现出显著的异质性,有不同的子组参与增殖和细胞间通信.
- 该研究确定了RARRES2作为OSC和TAM之间的关键基因中介通信.
- 与瘤相关的巨细胞通过胰岛素类生长因子1 (IGF-1) 信号传递促进OSC干,该信号可调节RARRES2.2.
结论:
- IGF-1/RARRES2轴是通过与TAMs的通信来维持OSC干性的关键途径.
- RARRES2 作为骨质肉瘤的潜在生物标志物.
- 针对已识别的沟通通路,可能为骨髓瘤提供新的治疗策略.
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:19Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K